Hemu Gene

禾沐基因

Hemu Gene

Biotech/Healthcare

Hemu Gene is a subsidiary of BGI Group. Guided by the vision of using genomics to benefit humanity, it leverages the research capabilities of the BGI Research Institute and BGI Group’s reach in healthcare to develop treatments for hemoglobin disorders, with the broader goal of eliminating…

Latest round: Strategic (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-08-01